Conference Coverage
NewsNetwork
OncLive TV
PEER EXCHANGE
OncLive INSIGHTS
VISITING CHICAGO? JOIN US IN RECOGNIZING OUR 2018 GIANTS OF CANCER CARE® ON MAY 31st AND VISIT BOOTH 2073 JUNE 2nd-4th!
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Prostate Cancer
Neoadjuvant HER2+
Brain Cancer
More >>

Ovarian Cancer Videos

Dr. Essel Discusses Adverse Events of Bevacizumab in Ovarian Cancer
Dr. Essel Discusses Adverse Events of Bevacizumab in Ovarian Cancer
Kathleen Essel, MD, fellow, University of Oklahoma Health Science Center, discusses adverse events with bevacizumab (Avastin) in ovarian cancer.
 
Onclive TV   >   
Dr. Cohen on the Evolution of Surgery in Ovarian Cancer
Dr. Cohen on the Evolution of Surgery in Ovarian Cancer
Joshua G. Cohen, MD, assistant professor, Division of Gynecologic Oncology, University of California, Los Angeles, discusses the evolution of surgery in the treatment of patients with ovarian cancer.
Onclive TV   >   
Dr. Slamon on PARP Inhibitors in Ovarian Cancer
Dr. Slamon on PARP Inhibitors in Ovarian Cancer
Dennis J. Slamon, MD, PhD, director, Clinical/Translational Research, Revlon/University of California, Los Angeles (UCLA) Women's Cancer Research Program, Jonsson Comprehensive Cancer Center, UCLA, discusses the use of PARP inhibitors in the treatment of patients with ovarian cancer.
Onclive TV   >   
Dr. Monk on the FORWARD I Trial in Ovarian Cancer
Dr. Monk on the FORWARD I Trial in Ovarian Cancer
Bradley J. Monk, MD, FACOG, FACS, professor and director of the Division of Gynecologic Oncology at Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Arizona Oncology, discusses the FORWARD I trial in ovarian cancer.
Onclive TV   >   
Dr. Wingo Discusses Neoadjuvant Chemotherapy in Ovarian Cancer
Dr. Wingo Discusses Neoadjuvant Chemotherapy in Ovarian Cancer
Shana Wingo, MD, gynecologic oncologist, Arizona Oncology, discusses the use of neoadjuvant chemotherapy in the treatment of patients with ovarian cancer.
 
Onclive TV   >   
Dr. Essel Discusses Long-Term Bevacizumab in Ovarian Cancer
Dr. Essel Discusses Long-Term Bevacizumab in Ovarian Cancer
Kathleen Essel, MD, fellow, University of Oklahoma Health Science Center, discusses a study on the effects of long-term bevacizumab (Avastin) use in patients with ovarian cancer.
Onclive TV   >   
Dr. Borst on Homologous Recombination Deficiency in Patients With Ovarian Cancer
Dr. Borst on Homologous Recombination Deficiency in Patients With Ovarian Cancer
Matthew Borst, MD, director, GYN/Oncology, Banner Good Samaritan Regional Medical Center, clinical assistant professor of medicine, University of Arizona, Arizona Oncology, discusses homologous recombination deficiency (HRD) in patients with ovarian cancer.
Onclive TV   >   
Dr. Dalton on Toxicities in the Frontline Treatment of Ovarian Cancer
Dr. Dalton on Toxicities in the Frontline Treatment of Ovarian Cancer
Heather Dalton, MD, gynecologic oncologist, Arizona Oncology, discusses toxicities in the frontline treatment of patients with ovarian cancer.
 
Onclive TV   >   
Managing Ovarian Cancer Patients in the Future
Managing Ovarian Cancer Patients in the Future
Bradley J. Monk, MD, FACS, FACOG; Shannon N. Westin, MD, MPH; David O’Malley, MD; Ursula Matulonis, MD; and Matthew Powell, MD, provide insight on how investigational combination strategies will better personalize therapy in ovarian cancer in the future.
 
Peer Exchange   >   Advanced Ovarian Cancer: Practical Essentials
Therapy Selection in BRCA-Mutated Ovarian Cancer
Therapy Selection in BRCA-Mutated Ovarian Cancer
Bradley J. Monk, MD, FACS, FACOG; Matthew Powell, MD; David O’Malley, MD; Ursula Matulonis, MD; and Shannon N. Westin, MD, MPH, highlight potential strategies for sequencing therapy in BRCA-mutated ovarian cancer.
Peer Exchange   >   Advanced Ovarian Cancer: Practical Essentials
Next Page >>
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
Publication Bottom Border
Border Publication
 
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.
 
x